Sample Set Annotation Tool: Systems biology of vaccination for seasonal influenza in humans. GSE29619

Study Design
Assay
Sample Info
Files
Info
Samples
Group Sets
Analysis

Purpose

This SuperSeries is composed of the following SubSeries;

- GSE29614 Time Course of Young Adults Vaccinated with Influenza TIV Vaccine during 2007/08 Flu Season

- GSE29615 Time Course of Young Adults Vaccinated with Influenza LAIV Vaccine during 2008/09 Flu Season

- GSE29617 Time Course of Young Adults Vaccinated with Influenza TIV Vaccine during 2008/09 Flu Season

Hypothesis

Experimental Design

Refer to individual Series

Experimental Variables

Controls

Methods

Additional Information

Expected Samples:

163 Samples Loaded: 163

Species

Human (Homo sapiens)

Sample Source

PBMC

Disease

Influenza vaccine

Treatment Protocol

Growth Protocol

Extraction Protocol

Storage Conditions

Sample Set Spreadsheet

Please log in in order to upload files.

Samples Preview

Sample ID	!Sample Title	group	Cell type	vaccine	Subject id
GSM733843	2008 LAIV subject ID 1 at D0 post-vaccination	LAIV Day0	PBMC	LAIV (FluMist, MedImmune)	1
GSM733844	2008 LAIV subject ID 1 at D3 post-vaccination	LAIV Day3	PBMC	LAIV (FluMist, MedImmune)	1
GSM733845	2008 LAIV subject ID 1 at D7 post-vaccination	LAIV Day7	PBMC	LAIV (FluMist, MedImmune)	1
GSM733846	2008 LAIV subject ID 5 at D0 post-vaccination	LAIV Day0	PBMC	LAIV (FluMist, MedImmune)	5
GSM733847	2008 LAIV subject ID 5 at D3 post-vaccination	LAIV Day3	PBMC	LAIV (FluMist, MedImmune)	5

Please log in in order to upload files.

File
sampleset4000077_sampleannotations_Group.csv Sample Set Spreadsheet
sampleset4000077_sampleannotations_Group.csv Sample Set Spreadsheet

Samples Viewer / Editor

All fields are editable except the "Sample ID" column. To edit a cell, click within the cell. To edit a "date" cell, click on the calendar icon. To cancel an edit, press the ESC key.

Sample ID	!Sample Title	Group	Cell type	Vaccine	Subject id	Time point	Hai titer (day 0) - a/south dakota/6/2007 (h1n1)	Hai titer (day 0) - a/uruguay/716/2007 nymc x-175c (h3n2)	Hai titer (day 0) - b/florida 4/2006	Hai titer (day 28) - a/south dakota/6/2007 (h1n1)	Hai titer (day 28) - a/uruguay/716/2007 nymc x-175c (h3n2)	Hai titer (day 28) - b/florida 4/2006	Hai titer (day 0) - a/brisbane/59/2007 (h1n1)	Hai titer (day 0) - a/uruguay (h3n2)	Hai titer (day 0) - b/brisbane/3/2007	Hai titer (day 28) - a/brisbane/59/2007 (h1n1)	Hai titer (day 28) - a/uruguay (h3n2)	Hai titer (day 28) - b/brisbane/3/2007
GSM733843	2008 LAIV subject ID 1 at D0 post-vaccination	LAIV Day0	PBMC	LAIV (FluMist, MedImmune)	1	D0	40	40	20	40	40	40
GSM733844	2008 LAIV subject ID 1 at D3 post-vaccination	LAIV Day3	PBMC	LAIV (FluMist, MedImmune)	1	D3	40	40	20	40	40	40
GSM733845	2008 LAIV subject ID 1 at D7 post-vaccination	LAIV Day7	PBMC	LAIV (FluMist, MedImmune)	1	D7	40	40	20	40	40	40
GSM733846	2008 LAIV subject ID 5 at D0 post-vaccination	LAIV Day0	PBMC	LAIV (FluMist, MedImmune)	5	D0	5	5	5	5	5	5
GSM733847	2008 LAIV subject ID 5 at D3 post-vaccination	LAIV Day3	PBMC	LAIV (FluMist, MedImmune)	5	D3	5	5	5	5	5	5
GSM733848	2008 LAIV subject ID 5 at D7 post-vaccination	LAIV Day7	PBMC	LAIV (FluMist, MedImmune)	5	D7	5	5	5	5	5	5
GSM733849	2008 LAIV subject ID 6 at D0 post-vaccination	LAIV Day0	PBMC	LAIV (FluMist, MedImmune)	6	D0	5	5	5	5	5	5
GSM733850	2008 LAIV subject ID 6 at D3 post-vaccination	LAIV Day3	PBMC	LAIV (FluMist, MedImmune)	6	D3	5	5	5	5	5	5
GSM733851	2008 LAIV subject ID 6 at D7 post-vaccination	LAIV Day7	PBMC	LAIV (FluMist, MedImmune)	6	D7	5	5	5	5	5	5
GSM733852	2008 LAIV subject ID 14 at D0 post-vaccination	LAIV Day0	PBMC	LAIV (FluMist, MedImmune)	14	D0	5	5	5	5	5	5
GSM733853	2008 LAIV subject ID 14 at D3 post-vaccination	LAIV Day3	PBMC	LAIV (FluMist, MedImmune)	14	D3	5	5	5	5	5	5
GSM733854	2008 LAIV subject ID 14 at D7 post-vaccination	LAIV Day7	PBMC	LAIV (FluMist, MedImmune)	14	D7	5	5	5	5	5	5
GSM733855	2008 LAIV subject ID 22 at D0 post-vaccination	LAIV Day0	PBMC	LAIV (FluMist, MedImmune)	22	D0	5	5	5	5	5	5
GSM733856	2008 LAIV subject ID 22 at D3 post-vaccination	LAIV Day3	PBMC	LAIV (FluMist, MedImmune)	22	D3	5	5	5	5	5	5
GSM733857	2008 LAIV subject ID 22 at D7 post-vaccination	LAIV Day7	PBMC	LAIV (FluMist, MedImmune)	22	D7	5	5	5	5	5	5
GSM733858	2008 LAIV subject ID 24 at D0 post-vaccination	LAIV Day0	PBMC	LAIV (FluMist, MedImmune)	24	D0	5	5	5	5	5	5
GSM733859	2008 LAIV subject ID 24 at D3 post-vaccination	LAIV Day3	PBMC	LAIV (FluMist, MedImmune)	24	D3	5	5	5	5	5	5
GSM733860	2008 LAIV subject ID 24 at D7 post-vaccination	LAIV Day7	PBMC	LAIV (FluMist, MedImmune)	24	D7	5	5	5	5	5	5
GSM733861	2008 LAIV subject ID 25 at D0 post-vaccination	LAIV Day0	PBMC	LAIV (FluMist, MedImmune)	25	D0	320	10	10	320	20	20
GSM733862	2008 LAIV subject ID 25 at D3 post-vaccination	LAIV Day3	PBMC	LAIV (FluMist, MedImmune)	25	D3	320	10	10	320	20	20
GSM733863	2008 LAIV subject ID 25 at D7 post-vaccination	LAIV Day7	PBMC	LAIV (FluMist, MedImmune)	25	D7	320	10	10	320	20	20
GSM733864	2008 LAIV subject ID 26 at D0 post-vaccination	LAIV Day0	PBMC	LAIV (FluMist, MedImmune)	26	D0	20	5	20	5	5	20
GSM733865	2008 LAIV subject ID 26 at D3 post-vaccination	LAIV Day3	PBMC	LAIV (FluMist, MedImmune)	26	D3	20	5	20	5	5	20
GSM733866	2008 LAIV subject ID 26 at D7 post-vaccination	LAIV Day7	PBMC	LAIV (FluMist, MedImmune)	26	D7	20	5	20	5	5	20
GSM733867	2008 LAIV subject ID 33 at D0 post-vaccination	LAIV Day0	PBMC	LAIV (FluMist, MedImmune)	33	D0	5	5	20	5	20	20
GSM733868	2008 LAIV subject ID 33 at D3 post-vaccination	LAIV Day3	PBMC	LAIV (FluMist, MedImmune)	33	D3	5	5	20	5	20	20
GSM733869	2008 LAIV subject ID 33 at D7 post-vaccination	LAIV Day7	PBMC	LAIV (FluMist, MedImmune)	33	D7	5	5	20	5	20	20
GSM733870	2008 LAIV subject ID 40 at D0 post-vaccination	LAIV Day0	PBMC	LAIV (FluMist, MedImmune)	40	D0	80	10	5	80	10	5
GSM733871	2008 LAIV subject ID 40 at D3 post-vaccination	LAIV Day3	PBMC	LAIV (FluMist, MedImmune)	40	D3	80	10	5	80	10	5
GSM733872	2008 LAIV subject ID 40 at D7 post-vaccination	LAIV Day7	PBMC	LAIV (FluMist, MedImmune)	40	D7	80	10	5	80	10	5
GSM733873	2008 LAIV subject ID 41 at D0 post-vaccination	LAIV Day0	PBMC	LAIV (FluMist, MedImmune)	41	D0	5	10	5	5	10	5
GSM733874	2008 LAIV subject ID 41 at D3 post-vaccination	LAIV Day3	PBMC	LAIV (FluMist, MedImmune)	41	D3	5	10	5	5	10	5
GSM733875	2008 LAIV subject ID 41 at D7 post-vaccination	LAIV Day7	PBMC	LAIV (FluMist, MedImmune)	41	D7	5	10	5	5	10	5
GSM733876	2008 LAIV subject ID 45 at D0 post-vaccination	LAIV Day0	PBMC	LAIV (FluMist, MedImmune)	45	D0	5	5	5	5	10	5
GSM733877	2008 LAIV subject ID 45 at D3 post-vaccination	LAIV Day3	PBMC	LAIV (FluMist, MedImmune)	45	D3	5	5	5	5	10	5
GSM733878	2008 LAIV subject ID 49 at D0 post-vaccination	LAIV Day0	PBMC	LAIV (FluMist, MedImmune)	49	D0	5	5	5	5	5	5
GSM733879	2008 LAIV subject ID 49 at D3 post-vaccination	LAIV Day3	PBMC	LAIV (FluMist, MedImmune)	49	D3	5	5	5	5	5	5
GSM733880	2008 LAIV subject ID 49 at D7 post-vaccination	LAIV Day7	PBMC	LAIV (FluMist, MedImmune)	49	D7	5	5	5	5	5	5
GSM733881	2008 LAIV subject ID 50 at D0 post-vaccination	LAIV Day0	PBMC	LAIV (FluMist, MedImmune)	50	D0	40	20	5	40	20	5
GSM733882	2008 LAIV subject ID 50 at D3 post-vaccination	LAIV Day3	PBMC	LAIV (FluMist, MedImmune)	50	D3	40	20	5	40	20	5
GSM733883	2008 LAIV subject ID 50 at D7 post-vaccination	LAIV Day7	PBMC	LAIV (FluMist, MedImmune)	50	D7	40	20	5	40	20	5
GSM733884	2008 LAIV subject ID 52 at D0 post-vaccination	LAIV Day0	PBMC	LAIV (FluMist, MedImmune)	52	D0	5	20	5	10	20	5
GSM733885	2008 LAIV subject ID 52 at D3 post-vaccination	LAIV Day3	PBMC	LAIV (FluMist, MedImmune)	52	D3	5	20	5	10	20	5
GSM733886	2008 LAIV subject ID 52 at D7 post-vaccination	LAIV Day7	PBMC	LAIV (FluMist, MedImmune)	52	D7	5	20	5	10	20	5
GSM733887	2008 LAIV subject ID 55 at D0 post-vaccination	LAIV Day0	PBMC	LAIV (FluMist, MedImmune)	55	D0	20	160	5	20	160	5
GSM733888	2008 LAIV subject ID 55 at D3 post-vaccination	LAIV Day3	PBMC	LAIV (FluMist, MedImmune)	55	D3	20	160	5	20	160	5
GSM733889	2008 LAIV subject ID 55 at D7 post-vaccination	LAIV Day7	PBMC	LAIV (FluMist, MedImmune)	55	D7	20	160	5	20	160	5
GSM733890	2008 LAIV subject ID 56 at D0 post-vaccination	LAIV Day0	PBMC	LAIV (FluMist, MedImmune)	56	D0	5	5	5	20	5	5
GSM733891	2008 LAIV subject ID 56 at D3 post-vaccination	LAIV Day3	PBMC	LAIV (FluMist, MedImmune)	56	D3	5	5	5	20	5	5
GSM733892	2008 LAIV subject ID 56 at D7 post-vaccination	LAIV Day7	PBMC	LAIV (FluMist, MedImmune)	56	D7	5	5	5	20	5	5
GSM733893	2008 LAIV subject ID 59 at D0 post-vaccination	LAIV Day0	PBMC	LAIV (FluMist, MedImmune)	59	D0	40	20	5	80	20	5
GSM733894	2008 LAIV subject ID 59 at D3 post-vaccination	LAIV Day3	PBMC	LAIV (FluMist, MedImmune)	59	D3	40	20	5	80	20	5
GSM733895	2008 LAIV subject ID 59 at D7 post-vaccination	LAIV Day7	PBMC	LAIV (FluMist, MedImmune)	59	D7	40	20	5	80	20	5
GSM733896	2008 LAIV subject ID 60 at D0 post-vaccination	LAIV Day0	PBMC	LAIV (FluMist, MedImmune)	60	D0	20	5	80	20	5	80
GSM733897	2008 LAIV subject ID 60 at D3 post-vaccination	LAIV Day3	PBMC	LAIV (FluMist, MedImmune)	60	D3	20	5	80	20	5	80
GSM733898	2008 LAIV subject ID 60 at D7 post-vaccination	LAIV Day7	PBMC	LAIV (FluMist, MedImmune)	60	D7	20	5	80	20	5	80
GSM733899	2008 LAIV subject ID 61 at D0 post-vaccination	LAIV Day0	PBMC	LAIV (FluMist, MedImmune)	61	D0	5	40	5	5	40	5
GSM733900	2008 LAIV subject ID 61 at D3 post-vaccination	LAIV Day3	PBMC	LAIV (FluMist, MedImmune)	61	D3	5	40	5	5	40	5
GSM733901	2008 LAIV subject ID 61 at D7 post-vaccination	LAIV Day7	PBMC	LAIV (FluMist, MedImmune)	61	D7	5	40	5	5	40	5
GSM733902	2008 LAIV subject ID 62 at D0 post-vaccination	LAIV Day0	PBMC	LAIV (FluMist, MedImmune)	62	D0	5	5	5	5	5	5
GSM733903	2008 LAIV subject ID 62 at D3 post-vaccination	LAIV Day3	PBMC	LAIV (FluMist, MedImmune)	62	D3	5	5	5	5	5	5
GSM733904	2008 LAIV subject ID 62 at D7 post-vaccination	LAIV Day7	PBMC	LAIV (FluMist, MedImmune)	62	D7	5	5	5	5	5	5
GSM733905	2008 LAIV subject ID 66 at D0 post-vaccination	LAIV Day0	PBMC	LAIV (FluMist, MedImmune)	66	D0	5	5	5	5	5	5
GSM733906	2008 LAIV subject ID 66 at D3 post-vaccination	LAIV Day3	PBMC	LAIV (FluMist, MedImmune)	66	D3	5	5	5	5	5	5
GSM733907	2008 LAIV subject ID 66 at D7 post-vaccination	LAIV Day7	PBMC	LAIV (FluMist, MedImmune)	66	D7	5	5	5	5	5	5
GSM733908	2008 LAIV subject ID 71 at D0 post-vaccination	LAIV Day0	PBMC	LAIV (FluMist, MedImmune)	71	D0	160	5	5	160	5	5
GSM733909	2008 LAIV subject ID 71 at D3 post-vaccination	LAIV Day3	PBMC	LAIV (FluMist, MedImmune)	71	D3	160	5	5	160	5	5
GSM733910	2008 LAIV subject ID 71 at D7 post-vaccination	LAIV Day7	PBMC	LAIV (FluMist, MedImmune)	71	D7	160	5	5	160	5	5
GSM733911	2008 LAIV subject ID 76 at D0 post-vaccination	LAIV Day0	PBMC	LAIV (FluMist, MedImmune)	76	D0	5	5	5	5	80	5
GSM733912	2008 LAIV subject ID 76 at D3 post-vaccination	LAIV Day3	PBMC	LAIV (FluMist, MedImmune)	76	D3	5	5	5	5	80	5
GSM733913	2008 LAIV subject ID 76 at D7 post-vaccination	LAIV Day7	PBMC	LAIV (FluMist, MedImmune)	76	D7	5	5	5	5	80	5
GSM733914	2008 LAIV subject ID 77 at D0 post-vaccination	LAIV Day0	PBMC	LAIV (FluMist, MedImmune)	77	D0	5	5	5	5	5	5
GSM733915	2008 LAIV subject ID 77 at D3 post-vaccination	LAIV Day3	PBMC	LAIV (FluMist, MedImmune)	77	D3	5	5	5	5	5	5
GSM733916	2008 LAIV subject ID 77 at D7 post-vaccination	LAIV Day7	PBMC	LAIV (FluMist, MedImmune)	77	D7	5	5	5	5	5	5
GSM733917	2008 LAIV subject ID 79 at D0 post-vaccination	LAIV Day0	PBMC	LAIV (FluMist, MedImmune)	79	D0	5	5	5	20	5	5
GSM733918	2008 LAIV subject ID 79 at D3 post-vaccination	LAIV Day3	PBMC	LAIV (FluMist, MedImmune)	79	D3	5	5	5	20	5	5
GSM733919	2008 LAIV subject ID 79 at D7 post-vaccination	LAIV Day7	PBMC	LAIV (FluMist, MedImmune)	79	D7	5	5	5	20	5	5
GSM733920	2008 LAIV subject ID 81 at D0 post-vaccination	LAIV Day0	PBMC	LAIV (FluMist, MedImmune)	81	D0	5	5	5	5	5	5
GSM733921	2008 LAIV subject ID 81 at D3 post-vaccination	LAIV Day3	PBMC	LAIV (FluMist, MedImmune)	81	D3	5	5	5	5	5	5
GSM733922	2008 LAIV subject ID 81 at D7 post-vaccination	LAIV Day7	PBMC	LAIV (FluMist, MedImmune)	81	D7	5	5	5	5	5	5
GSM733923	2008 LAIV subject ID 82 at D0 post-vaccination	LAIV Day0	PBMC	LAIV (FluMist, MedImmune)	82	D0	5	5	5	5	5	5
GSM733924	2008 LAIV subject ID 82 at D3 post-vaccination	LAIV Day3	PBMC	LAIV (FluMist, MedImmune)	82	D3	5	5	5	5	5	5
GSM733925	2008 LAIV subject ID 82 at D7 post-vaccination	LAIV Day7	PBMC	LAIV (FluMist, MedImmune)	82	D7	5	5	5	5	5	5
GSM733942	2008 TIV subject ID 2 at D0 post-vaccination	TIV Day0	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	2	D0							5	5	5	160	80	40
GSM733943	2008 TIV subject ID 2 at D7 post-vaccination	TIV Day7	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	2	D7							5	5	5	160	80	40
GSM733944	2008 TIV subject ID 16 at D0 post-vaccination	TIV Day0	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	16	D0							20	5	5	20	5	5
GSM733945	2008 TIV subject ID 16 at D3 post-vaccination	TIV Day3	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	16	D3							20	5	5	20	5	5
GSM733946	2008 TIV subject ID 16 at D7 post-vaccination	TIV Day7	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	16	D7							20	5	5	20	5	5
GSM733947	2008 TIV subject ID 29 at D0 post-vaccination	TIV Day0	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	29	D0							10	5	20	640	640	80
GSM733948	2008 TIV subject ID 29 at D3 post-vaccination	TIV Day3	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	29	D3							10	5	20	640	640	80
GSM733949	2008 TIV subject ID 29 at D7 post-vaccination	TIV Day7	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	29	D7							10	5	20	640	640	80
GSM733950	2008 TIV subject ID 3 at D0 post-vaccination	TIV Day0	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	3	D0							160	5	80	160	80	80
GSM733951	2008 TIV subject ID 3 at D3 post-vaccination	TIV Day3	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	3	D3							160	5	80	160	80	80
GSM733952	2008 TIV subject ID 3 at D7 post-vaccination	TIV Day7	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	3	D7							160	5	80	160	80	80
GSM733953	2008 TIV subject ID 32 at D0 post-vaccination	TIV Day0	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	32	D0							320	40	160	320	160	160
GSM733954	2008 TIV subject ID 32 at D3 post-vaccination	TIV Day3	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	32	D3							320	40	160	320	160	160
GSM733955	2008 TIV subject ID 32 at D7 post-vaccination	TIV Day7	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	32	D7							320	40	160	320	160	160
GSM733956	2008 TIV subject ID 35 at D0 post-vaccination	TIV Day0	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	35	D0							5	5	5	20	5	5
GSM733957	2008 TIV subject ID 35 at D3 post-vaccination	TIV Day3	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	35	D3							5	5	5	20	5	5
GSM733958	2008 TIV subject ID 35 at D7 post-vaccination	TIV Day7	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	35	D7							5	5	5	20	5	5
GSM733959	2008 TIV subject ID 38 at D0 post-vaccination	TIV Day0	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	38	D0							20	5	5	20	5	5
GSM733960	2008 TIV subject ID 38 at D3 post-vaccination	TIV Day3	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	38	D3							20	5	5	20	5	5
GSM733961	2008 TIV subject ID 38 at D7 post-vaccination	TIV Day7	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	38	D7							20	5	5	20	5	5
GSM733962	2008 TIV subject ID 39 at D0 post-vaccination	TIV Day0	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	39	D0							320	80	320	320	320	320
GSM733963	2008 TIV subject ID 39 at D3 post-vaccination	TIV Day3	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	39	D3							320	80	320	320	320	320
GSM733964	2008 TIV subject ID 39 at D7 post-vaccination	TIV Day7	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	39	D7							320	80	320	320	320	320
GSM733965	2008 TIV subject ID 4 at D0 post-vaccination	TIV Day0	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	4	D0							640	5	80	640	80	160
GSM733966	2008 TIV subject ID 4 at D3 post-vaccination	TIV Day3	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	4	D3							640	5	80	640	80	160
GSM733967	2008 TIV subject ID 42 at D0 post-vaccination	TIV Day0	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	42	D0							5	5	5	5	5	5
GSM733968	2008 TIV subject ID 42 at D3 post-vaccination	TIV Day3	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	42	D3							5	5	5	5	5	5
GSM733969	2008 TIV subject ID 42 at D7 post-vaccination	TIV Day7	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	42	D7							5	5	5	5	5	5
GSM733970	2008 TIV subject ID 43 at D0 post-vaccination	TIV Day0	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	43	D0							10	5	40	320	320	160
GSM733971	2008 TIV subject ID 43 at D3 post-vaccination	TIV Day3	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	43	D3							10	5	40	320	320	160
GSM733972	2008 TIV subject ID 43 at D7 post-vaccination	TIV Day7	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	43	D7							10	5	40	320	320	160
GSM733973	2008 TIV subject ID 44 at D0 post-vaccination	TIV Day0	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	44	D0							160	20	5	160	320	160
GSM733974	2008 TIV subject ID 44 at D3 post-vaccination	TIV Day3	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	44	D3							160	20	5	160	320	160
GSM733975	2008 TIV subject ID 44 at D7 post-vaccination	TIV Day7	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	44	D7							160	20	5	160	320	160
GSM733976	2008 TIV subject ID 46 at D0 post-vaccination	TIV Day0	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	46	D0							40	320	80	80	640	80
GSM733977	2008 TIV subject ID 46 at D3 post-vaccination	TIV Day3	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	46	D3							40	320	80	80	640	80
GSM733978	2008 TIV subject ID 46 at D7 post-vaccination	TIV Day7	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	46	D7							40	320	80	80	640	80
GSM733979	2008 TIV subject ID 47 at D0 post-vaccination	TIV Day0	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	47	D0							160	640	40	160	640	40
GSM733980	2008 TIV subject ID 47 at D3 post-vaccination	TIV Day3	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	47	D3							160	640	40	160	640	40
GSM733981	2008 TIV subject ID 47 at D7 post-vaccination	TIV Day7	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	47	D7							160	640	40	160	640	40
GSM733982	2008 TIV subject ID 48 at D0 post-vaccination	TIV Day0	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	48	D0							640	5	20	160	80	160
GSM733983	2008 TIV subject ID 48 at D3 post-vaccination	TIV Day3	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	48	D3							640	5	20	160	80	160
GSM733984	2008 TIV subject ID 48 at D7 post-vaccination	TIV Day7	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	48	D7							640	5	20	160	80	160
GSM733985	2008 TIV subject ID 51 at D0 post-vaccination	TIV Day0	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	51	D0							80	5	40	160	320	80
GSM733986	2008 TIV subject ID 51 at D3 post-vaccination	TIV Day3	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	51	D3							80	5	40	160	320	80
GSM733987	2008 TIV subject ID 53 at D0 post-vaccination	TIV Day0	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	53	D0							40	5	20	40	40	160
GSM733988	2008 TIV subject ID 53 at D3 post-vaccination	TIV Day3	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	53	D3							40	5	20	40	40	160
GSM733989	2008 TIV subject ID 53 at D7 post-vaccination	TIV Day7	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	53	D7							40	5	20	40	40	160
GSM733990	2008 TIV subject ID 63 at D0 post-vaccination	TIV Day0	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	63	D0							5	5	5	40	40	5
GSM733991	2008 TIV subject ID 63 at D3 post-vaccination	TIV Day3	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	63	D3							5	5	5	40	40	5
GSM733992	2008 TIV subject ID 63 at D7 post-vaccination	TIV Day7	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	63	D7							5	5	5	40	40	5
GSM733993	2008 TIV subject ID 65 at D0 post-vaccination	TIV Day0	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	65	D0							5	20	20	40	40	20
GSM733994	2008 TIV subject ID 65 at D3 post-vaccination	TIV Day3	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	65	D3							5	20	20	40	40	20
GSM733995	2008 TIV subject ID 65 at D7 post-vaccination	TIV Day7	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	65	D7							5	20	20	40	40	20
GSM733996	2008 TIV subject ID 68 at D0 post-vaccination	TIV Day0	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	68	D0							5	5	5	320	5	5
GSM733997	2008 TIV subject ID 68 at D3 post-vaccination	TIV Day3	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	68	D3							5	5	5	320	5	5
GSM733998	2008 TIV subject ID 68 at D7 post-vaccination	TIV Day7	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	68	D7							5	5	5	320	5	5
GSM733999	2008 TIV subject ID 70 at D0 post-vaccination	TIV Day0	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	70	D0							5	5	5	80	5	5
GSM734000	2008 TIV subject ID 70 at D7 post-vaccination	TIV Day7	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	70	D7							5	5	5	80	5	5
GSM734001	2008 TIV subject ID 72 at D0 post-vaccination	TIV Day0	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	72	D0							5	5	5	40	40	5
GSM734002	2008 TIV subject ID 72 at D3 post-vaccination	TIV Day3	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	72	D3							5	5	5	40	40	5
GSM734003	2008 TIV subject ID 72 at D7 post-vaccination	TIV Day7	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	72	D7							5	5	5	40	40	5
GSM734004	2008 TIV subject ID 73 at D0 post-vaccination	TIV Day0	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	73	D0							5	5	5	80	160	80
GSM734005	2008 TIV subject ID 73 at D3 post-vaccination	TIV Day3	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	73	D3							5	5	5	80	160	80
GSM734006	2008 TIV subject ID 73 at D7 post-vaccination	TIV Day7	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	73	D7							5	5	5	80	160	80
GSM734007	2008 TIV subject ID 74 at D0 post-vaccination	TIV Day0	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	74	D0							5	5	5	40	160	5
GSM734008	2008 TIV subject ID 74 at D3 post-vaccination	TIV Day3	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	74	D3							5	5	5	40	160	5
GSM734009	2008 TIV subject ID 74 at D7 post-vaccination	TIV Day7	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	74	D7							5	5	5	40	160	5
GSM734010	2008 TIV subject ID 78 at D0 post-vaccination	TIV Day0	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	78	D0							20	5	5	20	80	5
GSM734011	2008 TIV subject ID 78 at D3 post-vaccination	TIV Day3	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	78	D3							20	5	5	20	80	5
GSM734012	2008 TIV subject ID 78 at D7 post-vaccination	TIV Day7	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	78	D7							20	5	5	20	80	5
GSM734013	2008 TIV subject ID 80 at D0 post-vaccination	TIV Day0	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	80	D0							80	5	20	80	5	20
GSM734014	2008 TIV subject ID 80 at D3 post-vaccination	TIV Day3	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	80	D3							80	5	20	80	5	20
GSM734015	2008 TIV subject ID 80 at D7 post-vaccination	TIV Day7	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	80	D7							80	5	20	80	5	20
GSM734016	2008 TIV subject ID 83 at D0 post-vaccination	TIV Day0	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	83	D0							5	5	10	80	5	80
GSM734017	2008 TIV subject ID 83 at D3 post-vaccination	TIV Day3	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	83	D3							5	5	10	80	5	80
GSM734018	2008 TIV subject ID 83 at D7 post-vaccination	TIV Day7	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	83	D7							5	5	10	80	5	80
GSM734019	2008 TIV subject ID 85 at D0 post-vaccination	TIV Day0	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	85	D0							80	5	320	80	40	40
GSM734020	2008 TIV subject ID 85 at D3 post-vaccination	TIV Day3	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	85	D3							80	5	320	80	40	40
GSM734021	2008 TIV subject ID 85 at D7 post-vaccination	TIV Day7	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	85	D7							80	5	320	80	40	40

Group Sets View in Gene Expression Browser

Name
All Samples	Default	View
In order to make new Group Sets or change settings, please log in.

Module Analysis

Group Set
All Samples

SIDRA